In Vitro Effects of an Olive Polyphenol–Bromelain Formulation on U87MG Glioblastoma Cells: Viability, Cell-Cycle Distribution, Cytokine Release, and Total Antioxidant Capacity
Molecules · 2026
DOI: 10.3390/molecules31183334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Enver Ciraci und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Biruni University, Zeytinburnu, 34010 Istanbul, Türkiye. Hauptthemen laut MEDLINE: Polyphenols, Antioxidants, Glioblastoma, Olea. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul Atlas University.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) remains difficult to treat, and natural bioactive formulations are being explored as experimental modifiers of tumor-associated cellular processes. This study examined a fixed-ratio olive polyphenol–bromelain formulation in U87MG cells and performed targeted phenolic characterization of its olive-derived component.
Methods
Seven phenolics were quantified by LC–MS/MS. U87MG cells were exposed to the formulation or a bromelain comparator. The MTT metabolic signal, DNA-content cell-cycle distribution, IL-6, IL-10, and extracellular total antioxidant capacity (TAC) were assessed.
Results
The total quantified phenolics were 483.22 mg/kg, with oleocanthal, oleuropein, and 3,4-DHPEA-EDA predominating. The formulation reduced the MTT signal more than bromelain at lower and intermediate concentrations, although the response became non-monotonic at higher concentrations. Combination-treated cells showed greater G0/G1 accumulation. Culture supernatants showed lower IL-6 and higher IL-10 and TAC relative to untreated controls.
Conclusions
The formulation was associated with changes in metabolic activity, cell-cycle distribution, and extracellular cytokine/redox readouts in U87MG cells. Because no polyphenol-only arm, direct cell-death assay, complete replicate-level inferential analysis, or non-tumoral comparator was available, the findings are descriptive and do not establish synergy, cytotoxicity, mechanism, tumor selectivity, or therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Biruni University, Zeytinburnu, 34010 Istanbul, Türkiye.
- Biruni Advanced Technology Application and Research Center (BAMER), Biruni University, 34015 Istanbul, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Biruni University, Zeytinburnu, 34015 Istanbul, Türkiye.
- Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Türkiye.
- Department of Histology and Embryology, Faculty of Medicine, Biruni University, 34015 Istanbul, Türkiye.
- Department of Chemistry, Faculty of Science, Hacettepe University, 06800 Ankara, Türkiye.
ORCID-Profile: Tugba Elgun, Halil Ibrahim Arslan, Asiye Gok Yurttas, Gul Ipek Gundogan
Förderung
- Istanbul Atlas University
Zitieren
APA
Ciraci, E., Elgun, T., Oltulu, Y. M., Arslan, H. I., Yurttas, A. G., Gundogan, G. I., Uzun, L., & Emekdas, G. (2026). In Vitro Effects of an Olive Polyphenol–Bromelain Formulation on U87MG Glioblastoma Cells: Viability, Cell-Cycle Distribution, Cytokine Release, and Total Antioxidant Capacity. Molecules. https://doi.org/10.3390/molecules31183334
Vancouver
Ciraci E, Elgun T, Oltulu YM, Arslan HI, Yurttas AG, Gundogan GI, et al. In Vitro Effects of an Olive Polyphenol–Bromelain Formulation on U87MG Glioblastoma Cells: Viability, Cell-Cycle Distribution, Cytokine Release, and Total Antioxidant Capacity. Molecules. 2026. doi:10.3390/molecules31183334
BibTeX
@article{Ciraci2026,
author = {Ciraci, Enver and Elgun, Tugba and Oltulu, Yasemin Musteri and Arslan, Halil Ibrahim and Yurttas, Asiye Gok and Gundogan, Gul Ipek and Uzun, Lokman and Emekdas, Gurol},
title = {In Vitro Effects of an Olive Polyphenol–Bromelain Formulation on U87MG Glioblastoma Cells: Viability, Cell-Cycle Distribution, Cytokine Release, and Total Antioxidant Capacity},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31183334}
}
EUVIMED